rss
Postgrad Med J 2010;86:79-82 doi:10.1136/pgmj.2009.089656
  • Original article

Diagnostic utility of anti-Ro52 detection in systemic autoimmunity

  1. Manish Dugar1,
  2. Sally Cox1,
  3. Vidya Limaye1,
  4. Tom Paul Gordon2,
  5. Peter John Roberts-Thomson2
  1. 1Royal Adelaide Hospital, Adelaide, Australia
  2. 2Flinders Medical Centre, Adelaide, Australia
  1. Correspondence to Dr Manish Dugar, Department of Rheumatology, Level 4 Eleanor Harrald Building, Royal Adelaide Hospital, North Terrace, Adelaide, South Australia 5042, Australia; manish.dugar{at}health.sa.gov.au

  1. Contributors All authors were involved in the planning and manuscript preparation. The laboratory tests and data gathering was performed by authors MD and SC.

  • Received 17 August 2009
  • Accepted 11 October 2009

Abstract

Objectives To determine the prevalence and diagnostic utility of monospecific anti-Ro52 (defined as an immune response against Ro-52 antigen in the absence of reactivity to Ro-60 antigen) reactivity in selected autoimmune diseases.

Study design Stored diagnostic non-consecutive serum samples obtained from patients with systemic lupus erythematosus (SLE), primary Sjögren's syndrome (pSS), systemic sclerosis, idiopathic inflammatory myopathies (IIM), rheumatoid arthritis, primary biliary cirrhosis and mixed essential cryoglobulinaemia were analysed by line immunoassay to detect the presence of anti-Ro52 and other autoantibodies.

Results Monospecific anti-Ro52 reactivity was found in 51 (12.7%) of the 402 samples tested. Anti-Ro52 was the most common serological marker in patients with IIM (35/147, 23.8%) and co-occurred with anti-Jo1 (10/18, 55.6%; p=0.02). The prevalence of anti-Ro52 reactivity was significantly more than anti-Ro60 reactivity in patients with IIM, systemic sclerosis, primary biliary cirrhosis, mixed essential cryoglobulinemia and pSS. The mean signal intensity of anti-Ro52 reactivity was significantly higher in pSS than SLE and associated with rheumatoid factor positivity. The mean signal intensity of anti-Ro52 correlated with anti-Ro60 and anti-La in pSS and SLE.

Conclusions Monospecific anti-Ro52 reactivity is not disease specific but may be of importance in patients with IIM. Furthermore, as anti-Ro52 reactivity is more prevalent than anti-Ro60 reactivity in certain autoimmune conditions, specific testing for their distinction in clinical practice is recommended.

Footnotes

  • Competing interests None.

  • Ethics approval This study was conducted with the approval of the Clinical Ethics Committee, Flinders Medical Centre, Adelaide, Australia.

  • Provenance and peer review Not commissioned; externally peer reviewed.

This Article

  1. Abstract
  2. Full text
  3. PDF

Services

  1. Email this link to a friend
  2. Alert me when this article is cited
  3. Alert me if a correction is posted
  4. Alert me when eletters are published
  5. Article Usage Statistics
  6. Similar articles in this journal
  7. Similar articles in Web of Science
  8. Similar articles in PubMed
  9. Add article to my folders
  10. Download to citation manager
  11. Request permissions

Responses

  1. Submit a response
  2. No responses published

Social bookmarking

Register for free content


Free sample
 This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of PMJ.
View free sample issue >>

Free archive
The full back archive is now available for PMJ. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006, back to volume 1 issue 1.
Register to access the free archive >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.